OCUL

OCULAR THERAPEUTIX, INC

Nasdaq · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Ocular Therapeutix develops bioresorbable hydrogel-based therapies for eye diseases, including treatments for retinal conditions and glaucoma designed to deliver drugs locally without repeated injections or eye drops.

Industry

Pharmaceutical Preparations

Headquarters

Bedford, MA

Exchange

Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
Anderman ToddChief Legal Officer	Sell	$87K	11,984at $7.29	Oct 8, 2026
Heier Jeffrey S.Chief Scientific Officer	Sell	$77K	10,869at $7.05	Oct 2, 2026
Kaiser PeterChief Development Officer	Sell	$70K	9,990at $7.05	Oct 2, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for OCUL.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable OCUL activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

US mobile number (optional)

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.